Minimal systems analysis of mitochondria-dependent apoptosis induced by cisplatin

Ji-Young Hong1, Kenjirou Hara2, Jun-Woo Kim3

  • 1BioLead Inc., 609 Korea Mediventure Center, Daegu 41061 Korea.

Insights

This study models the mitochondria-reactive oxygen species (ROS) pathway in cisplatin-induced apoptosis. The developed mathematical model predicts apoptosis levels and identifies a critical cisplatin concentration for saturation.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Systems Biology

Background:

  • Mitochondria-reactive oxygen species (ROS) play a critical role in cisplatin-induced apoptosis.
  • Understanding the complex molecular interactions within this pathway requires a comprehensive approach.
  • Quantitative modeling and systemic analysis of this pathway have not been previously attempted.

Purpose of the Study:

  • To develop a novel mathematical model of the mitochondria-ROS generating pathway in cisplatin-induced apoptosis.
  • To quantitatively analyze the dynamics of mitochondrial apoptosis using experimental data.
  • To predict apoptosis levels at various cisplatin concentrations and identify critical thresholds.

Main Methods:

  • Experiments were conducted to measure critical molecule concentrations in human mesothelioma H2052 and ρ(0) cells.
  • A novel mathematical model was developed based on experimental data.
  • Kinetic parameters were estimated, and model dynamics were analyzed through parametric perturbation.

Main Results:

  • A mathematical model accurately representing the essential dynamics of cisplatin-induced mitochondrial apoptosis was developed.
  • The model successfully predicted apoptosis levels for various cisplatin concentrations, including those beyond experimental range.
  • Parametric perturbation analysis revealed that apoptosis saturates beyond a specific cisplatin concentration.

Conclusions:

  • The developed mathematical model provides a quantitative framework for understanding mitochondria-ROS pathway dynamics in cisplatin-induced apoptosis.
  • The study predicts a saturation point for apoptosis, offering insights into drug response mechanisms.
  • This systems biology approach can guide further research into chemotherapy and apoptosis regulation.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.7K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.4K